Back to trial

Eligibility Pre-Screening

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 50%

1.Have you been diagnosed with a skin cancer or melanoma?